Halberd (HALB) Stock Overview

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

HALB Stock Information

Symbol

HALB

Address

PO Box 25Jackson Center, PA 16133United States

Founded

Trading hours

Website

https://halberdcorporation.com

Country

🇺🇸 United States

Phone Number

814 786 8849

Halberd (HALB) Price Chart

Halberd Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.003	N/A
Market Cap	$1.54M	N/A
Shares Outstanding	512.87M	0.09%
Employees	0	N/A
Shareholder Equity	-926.37K	27.26%

Valuation	2023	Change
P/S Ratio	564.63	N/A
P/B Ratio	-1.66	N/A

Growth	2023	Change
Return on Equity	0.4902	N/A

Earnings	2023	Change
Revenue	$2.73K	N/A
Earnings	-$454.07K	N/A
Gross Margin	0.4844	N/A
Operating Margin	-164.11	N/A
Net income margin	-166.63	N/A

Financial Strength	2023	Change
Total Assets	$12.28K	N/A
Cash on Hand	$6.92K	N/A
Debt to Equity	-1.0133	-1.00%
Current Ratio	0.0111	-47.34%